Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use
Condition(s):Opioid Use DisorderLast Updated:February 2, 2024Withdrawn
Hide Studies Not Open or Pending
Condition(s):Opioid Use DisorderLast Updated:February 2, 2024Withdrawn
Condition(s):Opioid Use Disorder; Chronic PainLast Updated:February 13, 2024Recruiting
Condition(s):Opioid Use DisorderLast Updated:March 17, 2023Completed
Condition(s):Opioid-use Disorder; Opioid DependenceLast Updated:August 15, 2022Recruiting
Condition(s):Major Depressive Disorder; Opioid-use DisorderLast Updated:March 5, 2024Completed
Condition(s):Opioid Use DisorderLast Updated:October 7, 2022Terminated
Condition(s):Opioid Use DisorderLast Updated:February 20, 2024Not yet recruiting
Condition(s):Substance-Related Disorders; Substance Use Disorders; Substance Abuse, Intravenous; Substance Withdrawal; Substance Abuse; Opioid-use Disorder; Opioid Use Disorder, Severe; Opioid UseLast Updated:September 13, 2023Completed
Condition(s):Opioid Use; Opioid-use DisorderLast Updated:November 1, 2022Completed
Condition(s):Opioid-use DisorderLast Updated:March 12, 2024Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.